跳至主要内容
临床试验/NCT04864951
NCT04864951已完成不适用

HPV Prevalence in Transpersons - a Prospective Study

Sophie Pils4 个研究点 分布在 2 个国家目标入组 203 人开始时间: 2021年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
203
试验地点
4
主要终点
HPV prevalence in transpeople

研究概览

简要总结

In this study, Human Papilloma Virus (HPV) prevalence will be determined once in the urine of 200 trans people. In addition, subjects will be asked to complete a questionnaire about their sexual orientation, which is adapted from the largest published study.

详细描述

All transpeople who visit the outpatient clinic are asked to participate in the study. After being informed and signing the Informed Consent Form, the subjects are asked to give first-void urine and fill out the survey. The urine samples are sent pseudonymously to the University of Ljubljana for analysis. The subjects will be informed about their results within 3 weeks.If the result is positive, the subjects will be offered voluntary further care in our HPV outpatient clinic. However, this will take place outside the study. The data collected there can be used for further analyses.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Transpeople
  • Age over 18 years
  • Sufficient knowledge of German

排除标准

  • Age under 18 years
  • Insufficient knowledge of German

结局指标

主要结局

HPV prevalence in transpeople

时间窗: one year

HPV prevalence in transpeople

次要结局

未报告次要终点

研究者

发起方
Sophie Pils
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sophie Pils

Clinical Professor

Medical University of Vienna

研究点 (4)

Loading locations...

相似试验